Search
for
Sort by
Research 121–150 of 1000+
- Elevated Ghrelin Plasma Levels in Patients with Polycystic Ovary Syndrome
- Trichogenic effect of low level laser therapy combined with platelet-rich plasma for the management of androgenetic alopecia
- Associations between sun sensitive pigmentary genes and serum prostate specific antigen levels
- Role of serum androgens and prostate-specific antigen levels in men with androgenetic alopecia
- Comparative Studies on Polyamine Levels in Plasma and Urine of Androgenic Alopecia Patients Treated with Finasteride for a Period of Three Years
- The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women
- Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial
- Levonorgestrel effects on serum androgens, sex hormone–binding globulin levels, hair shaft diameter, and sexual function
- 17-Oximino-5-androsten-3β-yl esters: synthesis, antiproliferative activity, acute toxicity, and effect on serum androgen level
- The Safety of Testosterone Therapy in Women
- Pharmacotherapy of polycystic ovary syndrome - an update
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Female Progressive Scalp Hair Loss Associated with Ovarian Thecoma
- The dose‐response of percutaneous oestradiol implants on the skeletons of postmenopausal women
- Evidence-based approach to cutaneous hyperandrogenism in women
- Role of insulin resistance and diet in acne
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Hormonal contraceptives: pharmacology tailored to women's health
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Increased Insulin Sensitivity by Metformin Enhances Intense-Pulsed-Light-Assisted Hair Removal in Patients with Polycystic Ovary Syndrome
- The Optimal Number of Ovarian Punctures to Be Applied During Laparoscopic Ovarian Diathermy in Women with Polycystic Ovarian Syndrome
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)